Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

BoLin Chen

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
ACS Nano|November 23, 2021
Tuning the Structure, Conductivity, and Wettability of Laser-Induced Graphene for Multiplexed Open Microfluidic Environmental Biosensing and Energy Storage DevicesBolin Chen, Zachary T Johnson, Delaney Sanborn, et al.
Eclinicalmedicine|January 23, 2024
Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II studyXingxiang Pu, Gen Lin, Maoliang Xiao, et al.
ACS Applied Materials & Interfaces|August 1, 2023
Wearable Flexible Perspiration Biosensors Using Laser-Induced Graphene and Polymeric Tape MicrofluidicsNate T Garland, Jacob Schmieder, Zachary T Johnson, et al.
Frontiers in Genetics|October 28, 2022
MBD2 mediates Th17 cell differentiation by regulating MINK1 in Th17-dominant asthmaZhifeng Chen, Yulin Shang, Yu Yuan, et al.
Lung Cancer (Amsterdam, Netherlands)|March 29, 2024
Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: A multicenter, randomized phase II trialXingxiang Pu, Zemin Xiao, Jia Li, et al.
Gastroenterology|March 20, 2021
Ethnicity Associations With Food Sensitization Are Mediated by Gut Microbiota Development in the First Year of LifeHein M Tun, Ye Peng, Bolin Chen, et al.
British Journal of Cancer|December 19, 2023
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancerBolin Chen, Wenxiu Yao, Xingya Li, et al.
Nature Communications|March 11, 2022
Clinical and genomic features of Chinese lung cancer patients with germline mutationsWenying Peng, Bin Li, Jin Li, et al.
Lancet (London, England)|May 29, 2026
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trialAnwen Xiong, Wenxiu Yao, Wei Zheng, et al.
Lancet (London, England)|March 8, 2025
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in ChinaAnwen Xiong, Lei Wang, Jianhua Chen, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
ACS Nano|November 23, 2021
Tuning the Structure, Conductivity, and Wettability of Laser-Induced Graphene for Multiplexed Open Microfluidic Environmental Biosensing and Energy Storage DevicesBolin Chen, Zachary T Johnson, Delaney Sanborn, et al.
Eclinicalmedicine|January 23, 2024
Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II studyXingxiang Pu, Gen Lin, Maoliang Xiao, et al.
ACS Applied Materials & Interfaces|August 1, 2023
Wearable Flexible Perspiration Biosensors Using Laser-Induced Graphene and Polymeric Tape MicrofluidicsNate T Garland, Jacob Schmieder, Zachary T Johnson, et al.
Frontiers in Genetics|October 28, 2022
MBD2 mediates Th17 cell differentiation by regulating MINK1 in Th17-dominant asthmaZhifeng Chen, Yulin Shang, Yu Yuan, et al.
Lung Cancer (Amsterdam, Netherlands)|March 29, 2024
Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: A multicenter, randomized phase II trialXingxiang Pu, Zemin Xiao, Jia Li, et al.
Gastroenterology|March 20, 2021
Ethnicity Associations With Food Sensitization Are Mediated by Gut Microbiota Development in the First Year of LifeHein M Tun, Ye Peng, Bolin Chen, et al.
British Journal of Cancer|December 19, 2023
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancerBolin Chen, Wenxiu Yao, Xingya Li, et al.
Nature Communications|March 11, 2022
Clinical and genomic features of Chinese lung cancer patients with germline mutationsWenying Peng, Bin Li, Jin Li, et al.
Lancet (London, England)|May 29, 2026
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trialAnwen Xiong, Wenxiu Yao, Wei Zheng, et al.
Lancet (London, England)|March 8, 2025
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in ChinaAnwen Xiong, Lei Wang, Jianhua Chen, et al.
Pageof 14